• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症标志物对 II 期结肠癌预后的影响取决于肿瘤的位置。

The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness.

机构信息

Department of Surgery, Veterans General Hospital, Taipei, Taiwan.

Division of Colon and Rectal Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, Taiwan.

出版信息

ANZ J Surg. 2023 Jan;93(1-2):182-195. doi: 10.1111/ans.18014. Epub 2022 Sep 12.

DOI:10.1111/ans.18014
PMID:36097407
Abstract

BACKGROUNDS

Accumulating evidence has reported a high correlation between inflammatory markers and oncological outcomes in colorectal cancer. In the present study, we aimed to assess the prognostic values of five inflammatory markers in stage II colon cancer patients with different tumour locations.

METHODS

The consecutive stage II colon adenocarcinoma patients undergoing curative resection were analysed retrospectively. ROC curves and the area under the curve (AUCs) via bootstrap method were used to analyse the prognostic impact of various inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), systemic immune-inflammation index (SII) and prognostic nutrition index (PNI).

RESULTS

A total of 768 patients were enrolled for analysis. In univariate analysis, right-sided colon cancer (RCC) patients have significantly higher mean levels of all inflammatory markers than left-sided colon cancer (LCC) patients. In multivariate analyses, high NLR in LCC (P = 0.025) and low PNI in both RCC (P = 0.049) and LCC (P = 0.027) were significantly associated with a worse OS while none of the inflammatory markers was found to have a significant impact on DFS or CSS.

CONCLUSIONS

The profiles and prognostic impact of inflammatory markers are significantly different between stage II RCC and LCC patients. Researchers should take sidedness into consideration when addressing survival analysis of inflammatory markers.

摘要

背景

越来越多的证据表明炎症标志物与结直肠癌的肿瘤学结果之间存在高度相关性。本研究旨在评估五种炎症标志物在不同肿瘤部位的 II 期结肠癌患者中的预后价值。

方法

回顾性分析连续接受根治性切除术的 II 期结肠腺癌患者。通过 bootstrap 方法绘制 ROC 曲线和曲线下面积(AUCs),分析包括中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、淋巴细胞与单核细胞比值(LMR)、全身免疫炎症指数(SII)和预后营养指数(PNI)在内的各种炎症标志物的预后影响。

结果

共纳入 768 例患者进行分析。在单因素分析中,右半结肠癌(RCC)患者的所有炎症标志物的平均水平均显著高于左半结肠癌(LCC)患者。多因素分析显示,LCC 中 NLR 较高(P=0.025)和 RCC 及 LCC 中 PNI 较低(P=0.049 和 P=0.027)与 OS 较差显著相关,而其他炎症标志物均与 DFS 或 CSS 无显著相关性。

结论

II 期 RCC 和 LCC 患者的炎症标志物特征和预后影响显著不同。研究人员在进行炎症标志物生存分析时应考虑肿瘤侧别。

相似文献

1
The impact of inflammatory markers on prognosis of stage II colon cancers depends on tumour sidedness.炎症标志物对 II 期结肠癌预后的影响取决于肿瘤的位置。
ANZ J Surg. 2023 Jan;93(1-2):182-195. doi: 10.1111/ans.18014. Epub 2022 Sep 12.
2
Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.右侧结肠癌与左侧结肠癌患者血小板与淋巴细胞比值的临床基线和预后差异。
BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8.
3
Prognostic impact of tumour sidedness in patients with stage II colon cancer: a single-centre retrospective study.肿瘤侧别对 II 期结肠癌患者预后的影响:一项单中心回顾性研究。
ANZ J Surg. 2021 Apr;91(4):E196-E202. doi: 10.1111/ans.16638. Epub 2021 Feb 8.
4
Differences in oncological outcomes and inflammatory biomarkers between right-sided and left-sided stage I-III colorectal adenocarcinoma.右半侧和左半侧 I-III 期结直肠腺癌的肿瘤学结局和炎症生物标志物的差异。
J Clin Lab Anal. 2020 Apr;34(4):e23132. doi: 10.1002/jcla.23132. Epub 2019 Nov 21.
5
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer.术前预后营养指数在III期结肠癌患者中的预后价值及其与全身炎症反应标志物的相关性
Chin J Cancer. 2017 Dec 21;36(1):96. doi: 10.1186/s40880-017-0260-1.
6
[Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].[直肠癌患者术前炎症指标与预后的关系及预后列线图预测模型的建立]
Zhonghua Zhong Liu Za Zhi. 2022 May 23;44(5):402-409. doi: 10.3760/cma.j.cn112152-20200630-00612.
7
Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.预后营养指数和全身免疫炎症指数在口腔癌治疗中的应用。
BMC Cancer. 2022 Apr 7;22(1):368. doi: 10.1186/s12885-022-09439-x.
8
The impact of neutrophil-to-lymphocyte, platelet-to-lymphocyte and haemoglobin-to-platelet ratio on localised renal cell carcinoma oncologic outcomes.中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值及血红蛋白与血小板比值对局限性肾细胞癌肿瘤学结局的影响。
Prog Urol. 2019 Jul-Aug;29(8-9):423-431. doi: 10.1016/j.purol.2019.05.008. Epub 2019 Jun 10.
9
The effects of chemotherapy, primary tumor location and histological subtype on the survival of stage III colon cancer patients.化疗、原发肿瘤部位和组织学亚型对 III 期结肠癌患者生存的影响。
BMC Gastroenterol. 2023 Apr 5;23(1):110. doi: 10.1186/s12876-023-02741-3.
10
Outcomes of right-sided and left-sided colon cancer after curative resection.右半结肠癌和左半结肠癌根治性切除术后的结局。
Sci Rep. 2022 Jul 5;12(1):11323. doi: 10.1038/s41598-022-15571-2.

引用本文的文献

1
Are Calculated Immune Markers with or Without Comorbidities Good Predictors of Colorectal Cancer Survival? The Results of a Longitudinal Study.有无合并症的计算免疫标志物能否有效预测结直肠癌的生存率?一项纵向研究的结果
Med Sci (Basel). 2025 Aug 1;13(3):108. doi: 10.3390/medsci13030108.
2
Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer.用于结肠癌预后、肿瘤免疫微环境评估及候选药物开发的线粒体相关基因特征的综合分析
Sci Rep. 2025 Feb 20;15(1):6173. doi: 10.1038/s41598-024-85035-2.
3
Pan-immune-inflammation value as a prognostic biomarker for colon cancer and its variation by primary tumor location.
全身性免疫炎症指数作为结直肠癌的预后生物标志物及其与原发肿瘤位置的变化关系。
World J Gastroenterol. 2024 Sep 7;30(33):3823-3836. doi: 10.3748/wjg.v30.i33.3823.